Global Cyclic Peptide Compounds Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Cyclic Peptide Compounds Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

According to APO Research, The global Cyclic Peptide Compounds market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Cyclic Peptide Compounds is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Cyclic Peptide Compounds include Apellis Pharmaceuticals, Bachem, Bicycle Therapeutics, Merck, Roche (Chugai Pharmabody Research), Pfizer, Novartis and Biopharma PEG Scientific, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclic Peptide Compounds, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclic Peptide Compounds.

The Cyclic Peptide Compounds market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cyclic Peptide Compounds market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Apellis Pharmaceuticals
Bachem
Bicycle Therapeutics
Merck
Roche (Chugai Pharmabody Research)
Pfizer
Novartis
Biopharma PEG Scientific

Cyclic Peptide Compounds segment by Type

Synthetic Cyclic Peptide
Natural Cyclic Peptide

Cyclic Peptide Compounds segment by Application

Biopharmaceutical
Scientific Research
Environmental Protection
Others

Cyclic Peptide Compounds Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclic Peptide Compounds market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cyclic Peptide Compounds and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclic Peptide Compounds.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cyclic Peptide Compounds manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cyclic Peptide Compounds in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Cyclic Peptide Compounds Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Cyclic Peptide Compounds Sales Estimates and Forecasts (2019-2030)
1.3 Cyclic Peptide Compounds Market by Type
1.3.1 Synthetic Cyclic Peptide
1.3.2 Natural Cyclic Peptide
1.4 Global Cyclic Peptide Compounds Market Size by Type
1.4.1 Global Cyclic Peptide Compounds Market Size Overview by Type (2019-2030)
1.4.2 Global Cyclic Peptide Compounds Historic Market Size Review by Type (2019-2024)
1.4.3 Global Cyclic Peptide Compounds Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Cyclic Peptide Compounds Sales Breakdown by Type (2019-2024)
1.5.2 Europe Cyclic Peptide Compounds Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Cyclic Peptide Compounds Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Cyclic Peptide Compounds Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Cyclic Peptide Compounds Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Cyclic Peptide Compounds Industry Trends
2.2 Cyclic Peptide Compounds Industry Drivers
2.3 Cyclic Peptide Compounds Industry Opportunities and Challenges
2.4 Cyclic Peptide Compounds Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Cyclic Peptide Compounds Revenue (2019-2024)
3.2 Global Top Players by Cyclic Peptide Compounds Sales (2019-2024)
3.3 Global Top Players by Cyclic Peptide Compounds Price (2019-2024)
3.4 Global Cyclic Peptide Compounds Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Cyclic Peptide Compounds Key Company Manufacturing Sites & Headquarters
3.6 Global Cyclic Peptide Compounds Company, Product Type & Application
3.7 Global Cyclic Peptide Compounds Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Cyclic Peptide Compounds Market CR5 and HHI
3.8.2 Global Top 5 and 10 Cyclic Peptide Compounds Players Market Share by Revenue in 2023
3.8.3 2023 Cyclic Peptide Compounds Tier 1, Tier 2, and Tier 3
4 Cyclic Peptide Compounds Regional Status and Outlook
4.1 Global Cyclic Peptide Compounds Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Cyclic Peptide Compounds Historic Market Size by Region
4.2.1 Global Cyclic Peptide Compounds Sales in Volume by Region (2019-2024)
4.2.2 Global Cyclic Peptide Compounds Sales in Value by Region (2019-2024)
4.2.3 Global Cyclic Peptide Compounds Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Cyclic Peptide Compounds Forecasted Market Size by Region
4.3.1 Global Cyclic Peptide Compounds Sales in Volume by Region (2025-2030)
4.3.2 Global Cyclic Peptide Compounds Sales in Value by Region (2025-2030)
4.3.3 Global Cyclic Peptide Compounds Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Cyclic Peptide Compounds by Application
5.1 Cyclic Peptide Compounds Market by Application
5.1.1 Biopharmaceutical
5.1.2 Scientific Research
5.1.3 Environmental Protection
5.1.4 Others
5.2 Global Cyclic Peptide Compounds Market Size by Application
5.2.1 Global Cyclic Peptide Compounds Market Size Overview by Application (2019-2030)
5.2.2 Global Cyclic Peptide Compounds Historic Market Size Review by Application (2019-2024)
5.2.3 Global Cyclic Peptide Compounds Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Cyclic Peptide Compounds Sales Breakdown by Application (2019-2024)
5.3.2 Europe Cyclic Peptide Compounds Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Cyclic Peptide Compounds Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Cyclic Peptide Compounds Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Cyclic Peptide Compounds Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Apellis Pharmaceuticals
6.1.1 Apellis Pharmaceuticals Comapny Information
6.1.2 Apellis Pharmaceuticals Business Overview
6.1.3 Apellis Pharmaceuticals Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Apellis Pharmaceuticals Cyclic Peptide Compounds Product Portfolio
6.1.5 Apellis Pharmaceuticals Recent Developments
6.2 Bachem
6.2.1 Bachem Comapny Information
6.2.2 Bachem Business Overview
6.2.3 Bachem Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bachem Cyclic Peptide Compounds Product Portfolio
6.2.5 Bachem Recent Developments
6.3 Bicycle Therapeutics
6.3.1 Bicycle Therapeutics Comapny Information
6.3.2 Bicycle Therapeutics Business Overview
6.3.3 Bicycle Therapeutics Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bicycle Therapeutics Cyclic Peptide Compounds Product Portfolio
6.3.5 Bicycle Therapeutics Recent Developments
6.4 Merck
6.4.1 Merck Comapny Information
6.4.2 Merck Business Overview
6.4.3 Merck Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Cyclic Peptide Compounds Product Portfolio
6.4.5 Merck Recent Developments
6.5 Roche (Chugai Pharmabody Research)
6.5.1 Roche (Chugai Pharmabody Research) Comapny Information
6.5.2 Roche (Chugai Pharmabody Research) Business Overview
6.5.3 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Roche (Chugai Pharmabody Research) Cyclic Peptide Compounds Product Portfolio
6.5.5 Roche (Chugai Pharmabody Research) Recent Developments
6.6 Pfizer
6.6.1 Pfizer Comapny Information
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Cyclic Peptide Compounds Product Portfolio
6.6.5 Pfizer Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Novartis Cyclic Peptide Compounds Product Portfolio
6.7.5 Novartis Recent Developments
6.8 Biopharma PEG Scientific
6.8.1 Biopharma PEG Scientific Comapny Information
6.8.2 Biopharma PEG Scientific Business Overview
6.8.3 Biopharma PEG Scientific Cyclic Peptide Compounds Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biopharma PEG Scientific Cyclic Peptide Compounds Product Portfolio
6.8.5 Biopharma PEG Scientific Recent Developments
7 North America by Country
7.1 North America Cyclic Peptide Compounds Sales by Country
7.1.1 North America Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Cyclic Peptide Compounds Sales by Country (2019-2024)
7.1.3 North America Cyclic Peptide Compounds Sales Forecast by Country (2025-2030)
7.2 North America Cyclic Peptide Compounds Market Size by Country
7.2.1 North America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Cyclic Peptide Compounds Market Size by Country (2019-2024)
7.2.3 North America Cyclic Peptide Compounds Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Cyclic Peptide Compounds Sales by Country
8.1.1 Europe Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Cyclic Peptide Compounds Sales by Country (2019-2024)
8.1.3 Europe Cyclic Peptide Compounds Sales Forecast by Country (2025-2030)
8.2 Europe Cyclic Peptide Compounds Market Size by Country
8.2.1 Europe Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Cyclic Peptide Compounds Market Size by Country (2019-2024)
8.2.3 Europe Cyclic Peptide Compounds Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Cyclic Peptide Compounds Sales by Country
9.1.1 Asia-Pacific Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Cyclic Peptide Compounds Sales by Country (2019-2024)
9.1.3 Asia-Pacific Cyclic Peptide Compounds Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Cyclic Peptide Compounds Market Size by Country
9.2.1 Asia-Pacific Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Cyclic Peptide Compounds Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Cyclic Peptide Compounds Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Cyclic Peptide Compounds Sales by Country
10.1.1 Latin America Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Cyclic Peptide Compounds Sales by Country (2019-2024)
10.1.3 Latin America Cyclic Peptide Compounds Sales Forecast by Country (2025-2030)
10.2 Latin America Cyclic Peptide Compounds Market Size by Country
10.2.1 Latin America Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Cyclic Peptide Compounds Market Size by Country (2019-2024)
10.2.3 Latin America Cyclic Peptide Compounds Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Cyclic Peptide Compounds Sales by Country
11.1.1 Middle East and Africa Cyclic Peptide Compounds Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Cyclic Peptide Compounds Sales by Country (2019-2024)
11.1.3 Middle East and Africa Cyclic Peptide Compounds Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Cyclic Peptide Compounds Market Size by Country
11.2.1 Middle East and Africa Cyclic Peptide Compounds Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Cyclic Peptide Compounds Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Cyclic Peptide Compounds Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Cyclic Peptide Compounds Value Chain Analysis
12.1.1 Cyclic Peptide Compounds Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Cyclic Peptide Compounds Production Mode & Process
12.2 Cyclic Peptide Compounds Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Cyclic Peptide Compounds Distributors
12.2.3 Cyclic Peptide Compounds Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings